Milestone Pharmaceuticals Inc. financial data

Symbol
MIST on Nasdaq
Location
Montreal, Quebec, Canada
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 653% % -59%
Debt-to-equity 2687% % 1214%
Return On Equity -2373% % -1463%
Return On Assets -85% % -71%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85,169,344 shares 60%
Common Stock, Shares, Outstanding 85,169,344 shares 60%
Entity Public Float $69,800,000 USD -27%
Common Stock, Value, Issued $311,776,000 USD 8.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $16,527,000 USD 4.1%
General and Administrative Expense $16,190,000 USD 0.48%
Operating Income (Loss) $57,231,000 USD -31%
Net Income (Loss) Attributable to Parent $58,012,000 USD -36%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $46,685,000 USD 265%
Cash, Cash Equivalents, and Short-term Investments $82,600,000 USD 8.1%
Assets, Current $86,670,000 USD 7%
Property, Plant and Equipment, Net $136,000 USD -32%
Operating Lease, Right-of-Use Asset $944,000 USD -38%
Assets $87,750,000 USD 6.1%
Employee-related Liabilities, Current $2,411,000 USD 21%
Liabilities, Current $10,524,000 USD 100%
Operating Lease, Liability, Noncurrent $519,000 USD -48%
Liabilities $67,249,000 USD 15%
Retained Earnings (Accumulated Deficit) $413,194,000 USD -16%
Stockholders' Equity Attributable to Parent $20,501,000 USD -15%
Liabilities and Equity $87,750,000 USD 6.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $13,952,000 USD -56%
Net Cash Provided by (Used in) Financing Activities $140,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $33,583,000 USD
Common Stock, Shares, Issued 85,169,344 shares 60%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $19,771,000 USD
Deferred Tax Assets, Valuation Allowance $89,353,000 USD 11%
Deferred Tax Assets, Gross $89,353,000 USD 11%
Operating Lease, Liability $1,445,000 USD -28%
Payments to Acquire Property, Plant, and Equipment $6,000 USD
Lessee, Operating Lease, Liability, to be Paid $1,594,000 USD -30%
Property, Plant and Equipment, Gross $488,000 USD 4.3%
Operating Lease, Liability, Current $483,000 USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $530,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year One $658,000 USD -2.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $149,000 USD -46%
Lessee, Operating Lease, Liability, to be Paid, Year Three $406,000 USD -23%
Deferred Tax Assets, Operating Loss Carryforwards $72,775,000 USD 9.2%
Additional Paid in Capital $66,270,000 USD 74%
Depreciation, Depletion and Amortization $27,000 USD -3.6%
Share-based Payment Arrangement, Expense $5,383,000 USD -13%
Interest Expense $3,393,000 USD 2542%